Prescribing of chloramphenicol and aplastic anaemia.
作者信息
Wade O L
出版信息
J Coll Gen Pract. 1966 Nov;12(3):277-86.
Abstract
摘要
相似文献
1
Prescribing of chloramphenicol and aplastic anaemia.氯霉素的处方与再生障碍性贫血
J Coll Gen Pract. 1966 Nov;12(3):277-86.
2
Prescribing of drugs reported to cause adverse reactions.据报告可引起不良反应的药物的处方开具情况。
Br J Prev Soc Med. 1972 Nov;26(4):205-11. doi: 10.1136/jech.26.4.205.
3
A prospective study of chloramphenicol induced aplastic anaemia in Nigerians.
Trop Geogr Med. 1993;45(4):159-61.
4
Aplastic anaemia following chloramphenicol therapy in Hamburg and surrounding districts.汉堡及周边地区氯霉素治疗后再生障碍性贫血
Postgrad Med J. 1974 Oct;50 Suppl 5(581):131-6.
5
Aplastic anaemia. II. Drug-induced aplastic anaemia.
Acta Med Scand. 1972 Oct;192(4):319-21.
6
Chloramphenicol-induced aplastic anaemia--should its topical use be abandoned?氯霉素所致再生障碍性贫血——其局部应用是否应被摒弃？
Singapore Med J. 1999 Jul;40(7):445-6.
7
Drug-induced aplastic anaemia in Sweden with special reference to chloramphenicol.
Postgrad Med J. 1974 Oct;50 Suppl 5:127-31.
8
Follow-up studies in chloramphenicol-induced aplastic anaemia.
Postgrad Med J. 1974 Oct;50 Suppl 5:136-42.
9
Chloramphenicol. Are concerns about aplastic anaemia justified?氯霉素。对再生障碍性贫血的担忧合理吗？
Drug Saf. 1992 May-Jun;7(3):167-9. doi: 10.2165/00002018-199207030-00001.
10
Ocular chloramphenicol and aplastic anaemia. Is there a link?眼部使用氯霉素与再生障碍性贫血。二者有关联吗？
Drug Saf. 1996 May;14(5):273-6. doi: 10.2165/00002018-199614050-00001.
引用本文的文献
1
Prescribing of chloramphenicol in general practice.全科医疗中氯霉素的处方情况。
Br Med J. 1967 Mar 18;1(5541):671-4. doi: 10.1136/bmj.1.5541.671.
2
An analysis of prescribing of an hypnotic in the community.社区中一种催眠药物的处方分析。
Br J Prev Soc Med. 1972 May;26(2):121-8. doi: 10.1136/jech.26.2.121.
3
Prescribing of drugs reported to cause adverse reactions.据报告可引起不良反应的药物的处方开具情况。
Br J Prev Soc Med. 1972 Nov;26(4):205-11. doi: 10.1136/jech.26.4.205.
4
The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden.药物消费的测量。北爱尔兰、挪威和瑞典的糖尿病药物情况。
Eur J Clin Pharmacol. 1975 Feb 28;8(2):83-9. doi: 10.1007/BF00561555.
5
Evidence to the Royal Commission on the National Health Service. 2. From the Committee of Professors of Clinical Pharmacology and Therapeutics, Association of Professors of Internal Medicine.提交给国民健康服务皇家委员会的证据。2. 来自临床药理学与治疗学教授委员会，内科教授协会。
Br J Clin Pharmacol. 1978 Jun;5(6):477-80. doi: 10.1111/j.1365-2125.1978.tb01660.x.
6
General-practitioner prescribing.全科医生开处方。
J R Coll Gen Pract. 1977 Feb;27(175):79-82.
本文引用的文献
1
PATTERN OF PRESCRIBING IN GENERAL PRACTICE.全科医疗中的处方模式
Br Med J. 1963 Sep 7;2(5357):604-7. doi: 10.1136/bmj.2.5357.604.
2
INFLUENCE OF DIFFERENT SOURCES OF THERAPEUTIC INFORMATION ON PRESCRIBING BY GENERAL PRACTITIONERS.不同治疗信息来源对全科医生开处方的影响
Br Med J. 1963 Sep 7;2(5357):599-604. doi: 10.1136/bmj.2.5357.599.
3
Thalidomide and congenital abnormalities.沙利度胺与先天性异常。
Lancet. 1962 Feb 10;1(7224):303-5. doi: 10.1016/s0140-6736(62)91248-5.
4
Thalidomide and malformations in Liverpool.
Lancet. 1962 Jun 16;1(7242):1270-3. doi: 10.1016/s0140-6736(62)92367-x.
5
Chloramphenicol--a new warning.氯霉素——一项新的警示。
JAMA. 1960 Dec 3;174:1853-4. doi: 10.1001/jama.1960.03030140075018.
Zotero 插件